Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001337739 | SCV001531352 | uncertain significance | Saldino-Mainzer syndrome | 2022-09-27 | criteria provided, single submitter | clinical testing | This sequence change falls in intron 17 of the IFT140 gene. It does not directly change the encoded amino acid sequence of the IFT140 protein. It affects a nucleotide within the consensus splice site. This variant is present in population databases (rs370629233, gnomAD 0.04%). This variant has been observed in individual(s) with clinical features of retinitis pigmentosa (Invitae). ClinVar contains an entry for this variant (Variation ID: 1034941). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant is not likely to affect RNA splicing. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Gene |
RCV003159201 | SCV003852898 | uncertain significance | not provided | 2022-10-03 | criteria provided, single submitter | clinical testing | In silico analysis supports that this variant does not alter splicing; Has not been previously published as pathogenic or benign to our knowledge |
Fulgent Genetics, |
RCV005005833 | SCV005642818 | uncertain significance | Saldino-Mainzer syndrome; Retinitis pigmentosa 80 | 2024-04-26 | criteria provided, single submitter | clinical testing |